Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lacy

Showing results (521-530 of 553) with videos related to

Pageof 56
Sort By:
Contemporary Clinical Trials|February 21, 2012
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogeneticsNicholas J Talley, G Richard Locke, Linda M Herrick, et al.
The British Journal of Dermatology|February 26, 2026
Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: A scoping reviewLucy Booth, Xinyi Chen, Katie Stoker, et al.
The Journal of Allergy and Clinical Immunology|November 21, 2017
Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammationMilica Vukmanovic-Stejic, Emma S Chambers, Mayte Suárez-Fariñas, et al.
The Journal of Investigative Dermatology|March 4, 2015
The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during AgingMilica Vukmanovic-Stejic, Daisy Sandhu, Judith A Seidel, et al.
The American Journal of Gastroenterology|April 25, 2018
Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panelRena Yadlapati, Michael F Vaezi, Marcelo F Vela, et al.
Scientific Reports|June 3, 2020
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)Ricarda M Hoffmann, Silvia Mele, Anthony Cheung, et al.
Blood|March 19, 2020
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network reportStuart E Lacy, Sharon L Barrans, Philip A Beer, et al.
Blood Advances|April 1, 2022
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research NetworkSimon Crouch, Daniel Painter, Sharon L Barrans, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2017
Targeting Anti-TGF-<i>β</i> Therapy to Fibrotic Kidneys with a Dual Specificity Antibody ApproachSteve McGaraughty, Rachel A Davis-Taber, Chang Z Zhu, et al.
Journal for Immunotherapy of Cancer|May 31, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanomaZena N Willsmore, Lucy Booth, Akshay Patel, et al.
Pageof 56

Showing results (521-530 of 553) with videos related to

Sort By:
Pageof 56
Contemporary Clinical Trials|February 21, 2012
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogeneticsNicholas J Talley, G Richard Locke, Linda M Herrick, et al.
The British Journal of Dermatology|February 26, 2026
Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: A scoping reviewLucy Booth, Xinyi Chen, Katie Stoker, et al.
The Journal of Allergy and Clinical Immunology|November 21, 2017
Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammationMilica Vukmanovic-Stejic, Emma S Chambers, Mayte Suárez-Fariñas, et al.
The Journal of Investigative Dermatology|March 4, 2015
The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during AgingMilica Vukmanovic-Stejic, Daisy Sandhu, Judith A Seidel, et al.
The American Journal of Gastroenterology|April 25, 2018
Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panelRena Yadlapati, Michael F Vaezi, Marcelo F Vela, et al.
Scientific Reports|June 3, 2020
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)Ricarda M Hoffmann, Silvia Mele, Anthony Cheung, et al.
Blood|March 19, 2020
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network reportStuart E Lacy, Sharon L Barrans, Philip A Beer, et al.
Blood Advances|April 1, 2022
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research NetworkSimon Crouch, Daniel Painter, Sharon L Barrans, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2017
Targeting Anti-TGF-<i>β</i> Therapy to Fibrotic Kidneys with a Dual Specificity Antibody ApproachSteve McGaraughty, Rachel A Davis-Taber, Chang Z Zhu, et al.
Journal for Immunotherapy of Cancer|May 31, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanomaZena N Willsmore, Lucy Booth, Akshay Patel, et al.
Pageof 56